Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CXCR5 Modified EGFR Targeted CAR-T Cells
i
Other names:
CXCR5 Modified EGFR Targeted CAR-T Cells, CXCR5 modified EGFR Chimeric Antigen Receptor Autologous T cells
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Hedy Group
Drug class:
EGFR-targeted CAR-T immunotherapy
Related drugs:
‹
EGFR806-specific CAR T-cell therapy (1)
CART-EGFR (0)
EGFR IL12 CART cells (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
SNC109 (0)
TmEGFR/IL13Rα2 01 CAR-T (0)
Undisclosed EGFR/B7H3 CAR-T (0)
EGFR806-specific CAR T-cell therapy (1)
CART-EGFR (0)
EGFR IL12 CART cells (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
SNC109 (0)
TmEGFR/IL13Rα2 01 CAR-T (0)
Undisclosed EGFR/B7H3 CAR-T (0)
›
Associations
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Study of CXCR5 Modified EGFE Chimeric Antigen Receptor Autologous T Cells in EGFR- Positive Patients With Advanced Non-small Cell Lung Cancer (NCT04153799)
Phase 1
Sun Yat-sen University
Sun Yat-sen University
Recruiting
Phase 1
Sun Yat-sen University
Recruiting
Last update posted :
05/12/2020
Initiation :
11/01/2019
Primary completion :
12/01/2021
Completion :
12/01/2022
EGFR • CXCL13
|
EGFR expression
|
CXCR5 Modified EGFR Targeted CAR-T Cells
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login